JIUZHITANG CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.1 CNY | -5.04% |
|
-6.03% | -19.96% |
| Apr. 25 | Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023 | CI |
| Apr. 02 | Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
JIUZHITANG CO.,Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The Company provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Companyâs main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -19.96% | 957M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- 000989 Stock
- News Jiuzhitang Co., Ltd.
- Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%
